Crestline Management, L.P. is an SEC-registered investment adviser based in Fort Worth, TX that reports managing 30 hedge funds on Form ADV. It reports $22.5 billion in regulatory assets under management. Its private funds, of all types, hold $12.6 billion in gross assets. Its disclosed U.S. stock holdings returned an estimated +46.6% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated +85.0% from Q3 2024 to Q2 2026, compared with +37.2% for the S&P 500, based on 13F filings.
- Regulatory assets under management
- $22.5 billionForm ADV Item 5.F
- Gross assets of private funds
- $12.6 billionAll private fund types, Form ADV
- Hedge funds managed
- 3037 private funds in total
- Employees
- 195Form ADV Item 5.A
- Registration
- SEC-registered adviserCRD 122711
- Latest Form ADV
- 08/28/2026Disciplinary disclosures: none reported
Estimated 13F portfolio performance
| Quarter | Est. 13F return | S&P 500 |
|---|---|---|
| Q2 2026 | +32.3% | +14.8% |
| Q1 2026 | +10.9% | -4.6% |
| Q4 2025 | +13.1% | +2.4% |
| Q3 2025 | +6.7% | +7.8% |
| Q2 2025 | +7.2% | +10.4% |
| Q1 2025 | -6.5% | -4.5% |
| Q4 2024 | -1.7% | +2.1% |
| Q3 2024 | +6.2% | +5.4% |
Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures
Largest disclosed holdings
- Denali Therapeutics Inc$49.1 million
- Sana Biotechnology Inc$2.6 million
- 8X8 Inc New$1.7 million
As of 2026-06-30, from 13F filing by Crestline Management, L.P..
From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. HedgeMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures